Answers are grounded in this paper and cite their sources.
Assesses plaque vulnerability in diabetic versus non-diabetic CAD patients, suggesting significant differences in plaque characteristics.
Background: Coronary artery disease [CAD] is a major determinant of the long-term prognosis among patients with diabetes mellitus [DM].The aim of the work: The aim of this study was to investigate coronary plaque vulnerability using multi-slice computed tomography [MSCT-CA] coronary angiography in diabetic and non-diabetic patients. Methods: 200 patients who underwent MSCT-CA were evaluated for the vulnerability of atherosclerotic coronary plaques. Patients were divided into Group I [100 patients with Type II DM] and Group II [100 non-diabetic patients].Results: The DM group's mean age was greater [P 0.003]. In groups I and II, hypertension was present in 71% vs. 47%, and history of previous PCI was present in 6% vs. 0% [P values 0.001 and 0.029, respectively]; smoking history revealed a barely statistically significant difference [P 0.059], and the mean serum LDL-c level in the two groups was 154.25±34.11 vs. 191.66±16.829, respectively [P <0.001]. Positive remodeling of plaques [100% vs. 33%] and Napkin’s ring [66% vs. 40%] and spotty calcification [45% vs. 35%] were more evident in the diabetic group than the non-diabetic group [P <0.001, <0.001, and 0.005, respectively]. Low-attenuation plaques were present [100% vs. 95%] in groups I and II with borderline statistical significance [P 0.059]. The most affected vessels in the diabetic group were the right coronary artery [RCA] and ramus intermedius [RI] at 36% and 13%, respectively [P <0.001], whereas the most affected vessel with severe luminal narrowing was the LAD [51% vs. 30%], which was more evident in the DM group than the non-DM group [P 0.002].Conclusion: Vulnerable coronary plaques were more evident in the diabetic group compared to the non-diabetic group. Positive remodeling of plaques, Napkin’s ring, spotty calcification, and severe luminal narrowing were the most significant signs of plaque vulnerability in the diabetic group.
No takes yet. Share an insight, caveat, or question.
Elbassuny et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: